Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
The Chemours Co has a consensus price target of $28.27 based on the ratings of 12 analysts. The high is $40 issued by RBC Capital on December 1, 2023. The low is $18 issued by JP Morgan on August 6, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, JP Morgan, and UBS on September 3, 2024, August 6, 2024, and August 6, 2024, respectively. With an average price target of $23 between Goldman Sachs, JP Morgan, and UBS, there's an implied 22.99% upside for The Chemours Co from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Chemours (NYSE:CC) was reported by Goldman Sachs on September 3, 2024. The analyst firm set a price target for $23.00 expecting CC to rise to within 12 months (a possible 22.99% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Chemours (NYSE:CC) was provided by Goldman Sachs, and Chemours maintained their neutral rating.
The last upgrade for The Chemours Co happened on July 9, 2024 when UBS raised their price target to $30. UBS previously had a neutral for The Chemours Co.
The last downgrade for The Chemours Co happened on March 5, 2024 when UBS changed their price target from $37 to $21 for The Chemours Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chemours, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chemours was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.
While ratings are subjective and will change, the latest Chemours (CC) rating was a maintained with a price target of $29.00 to $23.00. The current price Chemours (CC) is trading at is $18.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.